Paper33136284
Human gut microbiota/microbiome in health and diseases: a review.
Gomaa EZ. Antonie Van Leeuwenhoek, 2020. Cited by 975 papers, by iCite.
Cite this record
ConductScience Library. Human gut microbiota/microbiome in health and diseases: a review. Papers, record 33136284. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33136284
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastrointestinal Microbiome | Major topic |
| Microbiota | Major topic |
| Probiotics | Major topic |
| Dysbiosis | |
| Humans | |
| Infant, Newborn |
Source PubMed
Cited by751
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 975 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42973669 | Rubicon is a critical regulator of immune barrier integrity and limits enteric pathogen infection. | Front Immunol | 2026 | https://conductscience.org/library/papers/42973669 | PubMed |
| 42932086 | Gut microbiome in colorectal cancer: a dual regulator of tumor biology and therapeutic response. | Folia Microbiol (Praha) | 2026 | https://conductscience.org/library/papers/42932086 | PubMed |
| 42912418 | A stratified human colon model reveals SCFA cross-feeding-driven host-microbe dynamics associated with epithelial and immune responses. | Gut Microbes | 2026 | https://conductscience.org/library/papers/42912418 | PubMed |
| 42909261 | Engineering extracellular vesicles for inflammatory bowel disease and colitis-associated colorectal cancer: from therapeutic innovation to clinical translation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42909261 | PubMed |
| 42905329 | Gut microbiota characteristics in patients with inguinal hernia: a prospective observational study. | Hernia | 2026 | https://conductscience.org/library/papers/42905329 | PubMed |
| 42898166 | Gut microbiota-driven imbalance of the gut-brain-immune homeostatic network in constipation: Pathogenic mechanisms and evolving therapeutic prospects. | iScience | 2026 | https://conductscience.org/library/papers/42898166 | PubMed |
| 42885908 | Subverting colonization resistance: Salmonella pathogenesis at the interface of microbiota, metabolism and inflammasome. | Virulence | 2026 | https://conductscience.org/library/papers/42885908 | PubMed |
| 42883553 | Investigation of Oral Toxicity Mechanisms of Low-Molecular-Weight Polycyclic Aromatic Hydrocarbons and Probiotic Interventions Under the Framework of the "Gut-Lung Axis". | Foods | 2026 | https://conductscience.org/library/papers/42883553 | PubMed |
| 42859348 | The Gut-Brain Axis and Neurodegenerative Diseases: From Mechanistic Pathways to Therapeutic Interventions. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/42859348 | PubMed |
| 42858216 | The Gut Microbiota-Epilepsy Axis: Bibliometric Trends, Mechanistic Insights, and Microbiota-Targeted Next-Generation Therapeutic Opportunities. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42858216 | PubMed |
| 42828644 | Next-generation probiotics and microbiome-based therapeutics highlighting Akkermansia muciniphila and Amuc_1100. | World J Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/42828644 | PubMed |
| 42814738 | Butyrate triggers neuronal signaling via release of colonic serotonin in a microfluidic model of gut-brain axis. | Am J Physiol Gastrointest Liver Physiol | 2026 | https://conductscience.org/library/papers/42814738 | PubMed |
| 42797038 | The Impact of Ultra-Processed Foods on Chronic Kidney Disease Progression. | Nutrients | 2026 | https://conductscience.org/library/papers/42797038 | PubMed |
| 42787347 | Clinical characteristics of gut microbiota translocation after acute myocardial infarction and its impact on prognosis. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42787347 | PubMed |
| 42783432 | Cannabigerol at the Interface of the Gut Microbiota and EndoCannabinoidome: Mechanistic Insights into Inflammation and Pain Modulation. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42783432 | PubMed |
| 42778955 | Longitudinal changes in gut microbiota across reproductive states in wild baboons. | Microbiome | 2026 | https://conductscience.org/library/papers/42778955 | PubMed |
| 42754660 | Microbiome-host communication via vaccenic acid modulates LRH-1/NR5A2 activity and ameliorates metabolic liver disease. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/42754660 | PubMed |
| 42751072 | Gut microbes and benign prostatic hyperplasia: the role of dysbiosis. | Front Urol | 2026 | https://conductscience.org/library/papers/42751072 | PubMed |
| 42744850 | A prospective randomized controlled pilot study of gut microbiome modulation by Nigella sativa seed oil and thymoquinone metabolism in healthy volunteers: implications for gastrointestinal surgery. | Sci Rep | 2026 | https://conductscience.org/library/papers/42744850 | PubMed |
| 42729922 | Gut microbiota dynamics and metabolic pathways associated with bleomycin-induced pulmonary fibrosis progression. | PeerJ | 2026 | https://conductscience.org/library/papers/42729922 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33136284
GET https://conductscience.org/api/papers/v1/33136284/cited_by?page=2